Trial Profile
A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary) ; Almotriptan; Eletriptan; Frovatriptan; Naratriptan; Rizatriptan; Sumatriptan; Zolmitriptan
- Indications Migraine
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 29 Jun 2011 New trial record
- 01 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.